Matthew Hammond

Matthew Hammond is a Partner at RA Capital Management, a prominent life sciences investment firm based in Boston, MA. In his current role, Hammond leads investment activities and strategy development, focusing on identifying and supporting innovative healthcare and biotech companies. Previously, he served as Principal at RA Capital Management, where he conducted due diligence and was instrumental in key investment decisions.

Hammond’s investment expertise centers on the biotechnology and pharmaceutical sectors, with a particular emphasis on clinical-stage therapeutics and medical innovation. He has played a significant role in venture capital, structured finance, and special situations, including leading SPAC transactions for RA Capital targeting companies in radiopharmaceuticals and other advanced therapeutic areas. Hammond’s directorship experience includes serving on the board of Jnana Therapeutics, further highlighting his active involvement in nurturing development-stage companies in drug discovery and molecular innovation.

He holds a Ph.D. in Biomedical Science (Neuroscience) from The University of Connecticut Health Center, an MBA in Finance, and a B.S. in Environmental Health, with additional academic experience at the University of Connecticut and the University of Georgia. Hammond’s career is marked by distinctive contributions to healthcare investment, notably facilitating successful public market access for novel biopharmaceutical companies and advancing capital formation for emerging firms in the biotech industry.